14 specialized isotopes transforming oncology precision in 2026 In the first quarter of 2026, the global medical landscape is facing a seismic shift as advanced alpha-emitting isotopes move from experimental trials to standard clinical protocols. Healthcare systems in North America and Western Europe are prioritizing high-precision ligand therapies to combat late-stage metastatic cancers that...